Kevin Colclough
Overview
Explore the profile of Kevin Colclough including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
1776
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Prehn E, Crowley M, Fennell D, Kinsley B, Colclough K, Byrne M
Endocrinol Diabetes Metab Case Rep
. 2025 Feb;
2025(1).
PMID: 39922186
Summary: Heterozygous insulin receptor (INSR) mutations cause type A insulin resistance (IR), associated with a phenotype of IR; hyperandrogenism, oligomenorrhoea and acanthosis nigricans in the absence of obesity or lipoatrophy....
2.
Locke J, Spurrier B, Laver T, Houghton J, Colclough K, Weedon M, et al.
J Transl Med
. 2024 Dec;
22(1):1128.
PMID: 39707450
No abstract available.
3.
Katte J, Dehayem M, Colclough K, Sobngwi E
J Med Case Rep
. 2024 Oct;
18(1):506.
PMID: 39420387
Background: Maturity onset diabetes of the young is one of the commonest causes of monogenic diabetes and can easily be mistaken for type 1 diabetes. A diagnosis of maturity onset...
4.
Molecular mechanism of HNF-1A-mediated HNF4A gene regulation and promoter-driven HNF4A-MODY diabetes
Kind L, Molnes J, Tjora E, Raasakka A, Myllykoski M, Colclough K, et al.
JCI Insight
. 2024 Jun;
9(11).
PMID: 38855865
Monogenic diabetes is a gateway to precision medicine through molecular mechanistic insight. Hepatocyte nuclear factor 1A (HNF-1A) and HNF-4A are transcription factors that engage in crossregulatory gene transcription networks to...
5.
Shields B, Carlsson A, Patel K, Knupp J, Kaur A, Johnston D, et al.
Sci Rep
. 2024 May;
14(1):10589.
PMID: 38719926
Maturity Onset Diabetes of the Young (MODY) is a young-onset, monogenic form of diabetes without needing insulin treatment. Diagnostic testing is expensive. To aid decisions on who to test, we...
6.
Cannon S, Hall T, Hawkes G, Colclough K, Boggan R, Wright C, et al.
Hum Mol Genet
. 2023 Nov;
33(5):465-474.
PMID: 37988592
Whole genome sequencing (WGS) from large clinically unselected cohorts provides a unique opportunity to assess the penetrance and expressivity of rare and/or known pathogenic mitochondrial variants in population. Using WGS...
7.
Toffoli M, Chohan H, Mullin S, Jesuthasan A, Yalkic S, Koletsi S, et al.
Neurobiol Dis
. 2023 Nov;
188:106343.
PMID: 37926171
Background: Variants in the GBA1 gene cause the lysosomal storage disorder Gaucher disease (GD). They are also risk factors for Parkinson's disease (PD), and modify the expression of the PD...
8.
De Sousa S, Wu K, Colclough K, Rawlings L, Dubowsky A, Monnik M, et al.
Acta Diabetol
. 2023 Oct;
61(2):181-188.
PMID: 37812285
Aims: This study aims to describe the prevalence of monogenic diabetes in an Australian referral cohort, in relation to Exeter maturity-onset diabetes of the young (MODY) probability calculator (EMPC) scores...
9.
Tobias D, Merino J, Ahmad A, Aiken C, Benham J, Bodhini D, et al.
Nat Med
. 2023 Oct;
29(10):2438-2457.
PMID: 37794253
Precision medicine is part of the logical evolution of contemporary evidence-based medicine that seeks to reduce errors and optimize outcomes when making medical decisions and health recommendations. Diabetes affects hundreds...
10.
Murphy R, Colclough K, Pollin T, Ikle J, Svalastoga P, Maloney K, et al.
Commun Med (Lond)
. 2023 Oct;
3(1):136.
PMID: 37794142
Background: Monogenic diabetes presents opportunities for precision medicine but is underdiagnosed. This review systematically assessed the evidence for (1) clinical criteria and (2) methods for genetic testing for monogenic diabetes,...